Intellipharmaceutics International Inc. (IPCI)

[grill4thrills]

"SeroquelXR is far and away the only potential blockbuster of the bunch!"

I'm not so certain (in a positive way), I've been reading for a while now how big of a deal Seroquel is, and I definitely agree, but I'm going to give some love to another ANDA in their pipeline. A year ago Glucophage (indication for diabetes) had a market of $ 905M vs. a Seroquel market of $ 1.3B. The last I saw, both Glucophage and Seroquel had market sales of $ 1.3B. To me, that suggests that while Seroquel formerly had the largest market in terms of sales, the 40%+ annual sales growth of Glucophage has gone quietly unnoticed by many and could easily have a larger market than Seroquel (which sales remained relatively flat year over year) today. IPCI's Glucophage ANDA was filed back in 2010 so is still one of those "any day now" type of deals, and with a market of $ 1.3B and growing fast, it will merit a lot more attention and shareholder value than say the $ 168M market for Keppra. Competition on one vs. the other will surely play a factor, but thought 40%+ growth was worth a call out.